BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17429201)

  • 1. Impact of enteral supplements enriched with omega-3 fatty acids and/or omega-6 fatty acids, arginine and ribonucleic acid compounds on leptin levels and nutritional status in active Crohn's disease treated with prednisolone.
    Nielsen AA; Nielsen JN; Grønbaek H; Eivindson M; Vind I; Munkholm P; Brandslund I; Hey H
    Digestion; 2007; 75(1):10-6. PubMed ID: 17429201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 fatty acids inhibit an increase of proinflammatory cytokines in patients with active Crohn's disease compared with omega-6 fatty acids.
    Nielsen AA; Jørgensen LG; Nielsen JN; Eivindson M; Grønbaek H; Vind I; Hougaard DM; Skogstrand K; Jensen S; Munkholm P; Brandslund I; Hey H
    Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1121-8. PubMed ID: 16305726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of preoperative administration of omega-3 fatty acid-enriched supplement on inflammatory and immune responses in patients undergoing major surgery for cancer.
    Nakamura K; Kariyazono H; Komokata T; Hamada N; Sakata R; Yamada K
    Nutrition; 2005 Jun; 21(6):639-49. PubMed ID: 15925286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome.
    Daly JM; Lieberman MD; Goldfine J; Shou J; Weintraub F; Rosato EF; Lavin P
    Surgery; 1992 Jul; 112(1):56-67. PubMed ID: 1377838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional treatment for acquired immunodeficiency virus infection using an enterotropic peptide-based formula enriched with n-3 fatty acids: a randomized prospective trial.
    de Luis Román DA; Bachiller P; Izaola O; Romero E; Martin J; Arranz M; Eiros Bouza JM; Aller R
    Eur J Clin Nutr; 2001 Dec; 55(12):1048-52. PubMed ID: 11781670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission.
    Valentini L; Schaper L; Buning C; Hengstermann S; Koernicke T; Tillinger W; Guglielmi FW; Norman K; Buhner S; Ockenga J; Pirlich M; Lochs H
    Nutrition; 2008; 24(7-8):694-702. PubMed ID: 18499398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factors (IGFs) and IGF binding proteins in active Crohn's disease treated with omega-3 or omega-6 fatty acids and corticosteroids.
    Eivindson M; Grønbaek H; Nielsen JN; Frystyk J; Flyvbjerg A; Jørgensen L; Vind I; Munkholm P; Jensen S; Brandslund I; Hey H
    Scand J Gastroenterol; 2005 Oct; 40(10):1214-21. PubMed ID: 16265778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of unsaturated fat dietary supplements on blood lipids, and on markers of malnutrition and inflammation in hemodialysis patients.
    Ewers B; Riserus U; Marckmann P
    J Ren Nutr; 2009 Sep; 19(5):401-11. PubMed ID: 19541503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic and immune effects of dietary arginine, glutamine and omega-3 fatty acids supplementation in immunocompromised patients.
    Chuntrasakul C; Siltharm S; Sarasombath S; Sittapairochana C; Leowattana W; Chockvivatanavanit S; Bunnak A
    J Med Assoc Thai; 1998 May; 81(5):334-43. PubMed ID: 9623033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutritional and inflammatory status of hemodialysis patients in relation to their body mass index.
    Beberashvili I; Sinuani I; Azar A; Yasur H; Feldman L; Efrati S; Averbukh Z; Weissgarten J
    J Ren Nutr; 2009 May; 19(3):238-47. PubMed ID: 19243974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of omega 3 and omega 6 fatty acid intakes from diet and supplements on plasma fatty acid levels in the first 3 years of life.
    Hoyos C; Almqvist C; Garden F; Xuan W; Oddy WH; Marks GB; Webb KL
    Asia Pac J Clin Nutr; 2008; 17(4):552-7. PubMed ID: 19114389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omega-3 fatty acid supplementation effects on weight and appetite in patients with Alzheimer's disease: the omega-3 Alzheimer's disease study.
    Irving GF; Freund-Levi Y; Eriksdotter-Jönhagen M; Basun H; Brismar K; Hjorth E; Palmblad J; Vessby B; Vedin I; Wahlund LO; Cederholm T
    J Am Geriatr Soc; 2009 Jan; 57(1):11-7. PubMed ID: 19054188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of postoperative immune response by enteral nutrition with a diet enriched with arginine, RNA, and omega-3 fatty acids in patients with upper gastrointestinal cancer.
    Senkal M; Kemen M; Homann HH; Eickhoff U; Baier J; Zumtobel V
    Eur J Surg; 1995 Feb; 161(2):115-22. PubMed ID: 7539633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of a W3 fatty acids oral enhanced formula in clinical and biochemical parameters of head and neck cancer ambulatory patients].
    de Luis DA; Izaola O; Aller R; González-Sagrado M; Cuellar L; Terroba MC; Martín T
    An Med Interna; 2008 Jun; 25(6):275-8. PubMed ID: 19295974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive approach to evaluate nutritional status in Crohn's patients in the era of biologic therapy: a case-control study.
    Sousa Guerreiro C; Cravo M; Costa AR; Miranda A; Tavares L; Moura-Santos P; MarquesVidal P; Nobre Leitão C
    Am J Gastroenterol; 2007 Nov; 102(11):2551-6. PubMed ID: 17680845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of exclusive enteral nutritional treatment on plasma antioxidant concentrations in childhood Crohn's disease.
    Akobeng AK; Richmond K; Miller V; Thomas AG
    Clin Nutr; 2007 Feb; 26(1):51-6. PubMed ID: 17161887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
    da Silva TM; Munhoz RP; Alvarez C; Naliwaiko K; Kiss A; Andreatini R; Ferraz AC
    J Affect Disord; 2008 Dec; 111(2-3):351-9. PubMed ID: 18485485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of fatty acid contents of erythrocyte membrane in hemodialysis and peritoneal dialysis patients.
    An WS; Kim SE; Kim KH; Lee S; Park Y; Kim HJ; Vaziri ND
    J Ren Nutr; 2009 Jul; 19(4):267-74. PubMed ID: 19539181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease.
    Selby W; Pavli P; Crotty B; Florin T; Radford-Smith G; Gibson P; Mitchell B; Connell W; Read R; Merrett M; Ee H; Hetzel D;
    Gastroenterology; 2007 Jun; 132(7):2313-9. PubMed ID: 17570206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-lowering drugs and essential omega-6 and omega-3 fatty acids in patients with coronary heart disease.
    de Lorgeril M; Salen P; Guiraud A; Zeghichi S; Boucher F; de Leiris J
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):36-41. PubMed ID: 15871849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.